Tag Stone Capital, Inc. Amgen Inc Transaction History

Tag Stone Capital, Inc.

$192 Million
Q3 2024

A detailed history of Tag Stone Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Tag Stone Capital, Inc. holds 3,681 shares of AMGN stock, worth $978,961. This represents 0.62% of its overall portfolio holdings.

Number of Shares

3,681

Previous 3,656 0.68%

Holding current value

$978,961

Previous $1.14 Million 3.85%

% of portfolio

0.62%

Previous 0.66%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $7,734 - $8,434	25 Added 0.68%	3,681 $1.19 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $10,247 - $12,453	39 Added 1.08%	3,656 $1.14 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $8,066 - $9,736	30 Added 0.84%	3,617 $1.03 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $7,159 - $8,076	28 Added 0.79%	3,587 $1.03 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $6,122 - $7,600	28 Added 0.79%	3,559 $957,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $7,285 - $8,614	34 Added 0.97%	3,531 $784,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $7,225 - $8,806	32 Added 0.92%	3,497 $845,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $5,496 - $6,984	24 Added 0.7%	3,465 $910,000
Q3 2022 Nov 01, 2022	BUY	$224.46 - $253.15 $6,060 - $6,835	27 Added 0.79%	3,441 $776,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 0.77%	3,414 $831,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $6,139 - $6,791	28 Added 0.83%	3,388 $819,000
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $668,236 - $764,736	3,360 New	3,360 $756,000

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tag Stone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tag Stone Capital, Inc. with notifications on news.

Account

Tag Stone Capital, Inc. Amgen Inc Transaction History